Logo
About Us
OverviewLeadershipContact and Locations
Medicines
PortfolioApproved MedicineID/IDA Facts and FiguresPublications
Partnerships
Investor
Investor OverviewStock InformationFinancialsAnalysts & AdvisorsAIM Rule 26Corporate GovernanceMy Account
News & Media
NewsWebinarsMedia
Careers
Q&A

Chinese NMPA Accepts MAA Submission for ACCRUFeR® (ferric maltol)

RNS

Released

Latest announcements

Ask a question


Your question will be visible to everyone.

Investor Q&As

Start the conversation

Ask Shield Therapeutics a question about this announcement.